Showing results (151-160 of 342) with videos related to
Sort By:
Pageof 35
Respiratory Medicine|April 24, 2021
Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung diseaseAiko Saku, Tomoyuki Fujisawa, Koji Nishimoto, et al.Plos One|March 20, 2015
Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control studyHironao Hozumi, Noriyuki Enomoto, Masato Kono, et al.BMJ Open|September 17, 2013
Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control studyHironao Hozumi, Yutaro Nakamura, Takeshi Johkoh, et al.International Journal of Molecular Sciences|February 9, 2018
Inhibiting Skp2 E3 Ligase Suppresses Bleomycin-Induced Pulmonary FibrosisMasashi Mikamo, Kyoko Kitagawa, Satoshi Sakai, et al.Journal of Pain and Symptom Management|June 23, 2020
Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' ViewNorimichi Akiyama, Tomoyuki Fujisawa, Tatsuya Morita, et al.Scientific Reports|May 26, 2019
Physiological and morphological differences of airways between COPD and asthma-COPD overlapMasato Karayama, Naoki Inui, Hideki Yasui, et al.Oncology and Therapy|March 5, 2022
Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE)Akito Hata, Yoshimasa Shiraishi, Naoki Inui, et al.Respiratory Medicine|November 28, 2016
Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung diseaseHironao Hozumi, Tomoyuki Fujisawa, Ran Nakashima, et al.Therapeutic Advances in Respiratory Disease|February 13, 2020
Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung diseaseTakafumi Koyauchi, Hideki Yasui, Noriyuki Enomoto, et al.Respiratory Investigation|January 9, 2026
Epidemiology of interstitial lung diseases in Japan: A nationwide database analysisKoichi Miyashita, Yusuke Inoue, Hideki Yasui, et al.Pageof 35